• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从醇改性亚临界水中制备布地奈德颗粒。

Particle formation of budesonide from alcohol-modified subcritical water solutions.

机构信息

Supercritical Fluids Research Group, School of Chemical Sciences and Engineering, The University of New South Wales, Sydney, New South Wales 2052, Australia.

出版信息

Int J Pharm. 2011 Feb 28;405(1-2):169-80. doi: 10.1016/j.ijpharm.2010.11.042. Epub 2010 Dec 1.

DOI:10.1016/j.ijpharm.2010.11.042
PMID:21129462
Abstract

Recently, subcritical water (SBCW: water that has been heated to a temperature between 100°C and 200°C at pressures of up to 70bar) has been used to dissolve several hydrophobic pharmaceutical compounds (Carr et al., 2010a). Furthermore, a number of active pharmaceutical ingredients (APIs) have been rapidly precipitated from SBCW solutions (Carr et al., 2010b,c). It is possible to alter the precipitate morphology by altering the processing variables; including the SBCW-API solution injection temperature and adding impurities (such as pharmaceutical excipients, e.g. lactose) to the precipitation chamber. The work presented in this article demonstrates that the morphology of pharmaceutical particles can be tuned by adding organic solvents (ethanol and methanol) to the SBCW-API solutions. Particle morphology has also been tuned by adding different pharmaceutical excipients (polyethylene glycol 400 and lactose) to the precipitation chamber. Different morphologies of pharmaceutical particles were produced, ranging from nanospheres of 60nm diameter to 5μm plate particles. Budesonide was used as the model API in this study. Two experimental products were spray dried to form dry powder products. The aerodynamic particle size of the powder was established by running the powder through an Andersen Cascade Impactor. It has been shown that the drug particles produced from the SBCW micronization process, when coupled with a spray drying process, are suitable for delivery to the lungs.

摘要

最近,亚临界水(SBCW:在 100°C 至 200°C 的温度下加热至 70bar 以下的水)已被用于溶解几种疏水性药物化合物(Carr 等人,2010a)。此外,许多活性药物成分(APIs)已从 SBCW 溶液中快速沉淀(Carr 等人,2010b,c)。通过改变加工变量,可以改变沉淀的形态;包括 SBCW-API 溶液的注入温度和向沉淀室中添加杂质(如药物赋形剂,例如乳糖)。本文介绍的工作表明,通过向 SBCW-API 溶液中添加有机溶剂(乙醇和甲醇)可以调节药物颗粒的形态。通过向沉淀室中添加不同的药物赋形剂(聚乙二醇 400 和乳糖)也可以调节颗粒形态。生产出了不同形态的药物颗粒,从 60nm 直径的纳米球到 5μm 的板状颗粒。布地奈德被用作本研究的模型 API。两种实验产品通过喷雾干燥形成干粉产品。通过将粉末通过安德森级联撞击器运行来确定粉末的空气动力学粒径。结果表明,通过 SBCW 微细化工艺生产的药物颗粒与喷雾干燥工艺结合使用,适用于肺部给药。

相似文献

1
Particle formation of budesonide from alcohol-modified subcritical water solutions.从醇改性亚临界水中制备布地奈德颗粒。
Int J Pharm. 2011 Feb 28;405(1-2):169-80. doi: 10.1016/j.ijpharm.2010.11.042. Epub 2010 Dec 1.
2
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.湿度引起的含有不同载体的干粉气雾剂制剂空气动力学性质的变化。
Int J Pharm. 2007 Mar 21;333(1-2):45-55. doi: 10.1016/j.ijpharm.2006.09.048. Epub 2006 Oct 1.
3
Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.用于肺部给药的不含辅料的布地奈德纳米多孔微粒
Eur J Pharm Sci. 2009 Jul 12;37(5):593-602. doi: 10.1016/j.ejps.2009.05.007. Epub 2009 May 20.
4
Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying.使用微流控反应器结合超声喷雾冷冻干燥制备的新型布地奈德干粉吸入剂颗粒
J Pharm Sci. 2017 Jul;106(7):1881-1888. doi: 10.1016/j.xphs.2017.02.035. Epub 2017 Mar 9.
5
Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.喷雾干燥法制备可吸入共无定形布地奈德-精氨酸干粉。
Int J Pharm. 2019 Jun 30;565:1-8. doi: 10.1016/j.ijpharm.2019.04.036. Epub 2019 Apr 15.
6
Effervescent dry powder for respiratory drug delivery.用于呼吸道给药的泡腾干粉。
Eur J Pharm Biopharm. 2007 Mar;65(3):346-53. doi: 10.1016/j.ejpb.2006.10.021. Epub 2006 Nov 7.
7
Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation.主结晶条件对干粉吸入用微米化布地奈德的力学和界面性能的影响。
Int J Pharm. 2012 Jul 1;430(1-2):26-33. doi: 10.1016/j.ijpharm.2012.03.020. Epub 2012 Mar 17.
8
Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents.使用蛋白质稳定剂对喷雾干燥重组人生长激素进行表征及空气动力学评估。
Int J Pharm. 2008 Mar 20;352(1-2):209-16. doi: 10.1016/j.ijpharm.2007.10.053. Epub 2007 Nov 17.
9
Antisolvent crystallization of pharmaceutical excipients from aqueous solutions and the use of preferred orientation in phase identification by powder X-ray diffraction.药用辅料的抗溶剂结晶法及其在粉末 X 射线衍射相鉴定中的择优取向应用。
Eur J Pharm Sci. 2011 Apr 18;42(5):568-77. doi: 10.1016/j.ejps.2011.02.010. Epub 2011 Mar 5.
10
The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation.载体表面处理对用于吸入的粘合剂混合物中药物颗粒从结晶载体上脱离的影响。
Int J Pharm. 2006 Dec 11;327(1-2):17-25. doi: 10.1016/j.ijpharm.2006.07.017. Epub 2006 Jul 16.

引用本文的文献

1
Influence of Composition and Spray-Drying Process Parameters on Carrier-Free DPI Properties and Behaviors in the Lung: A review.成分及喷雾干燥工艺参数对无载体干粉吸入剂在肺部的性质和行为的影响:综述
Pharmaceutics. 2020 Jan 9;12(1):55. doi: 10.3390/pharmaceutics12010055.
2
NanoClusters surface area allows nanoparticle dissolution with microparticle properties.纳米团簇的表面积使纳米颗粒具有微粒特性并能溶解。
J Pharm Sci. 2014 Jun;103(6):1787-98. doi: 10.1002/jps.23980. Epub 2014 Apr 30.